Pulmonary Hypertension: Assessment of Cell Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Hypertension, Pulmonary
Interventions
BIOLOGICAL

eNOS transfected EPCs will be delivered via a PA line

incremental dosing over 3 days

Trial Locations (2)

M5B1W8

St. Michael's Hospital, Toronto

H3T 1E2

Sir Mortimer B. Davis - Jewish General Hospital, Montreal

Sponsors
All Listed Sponsors
collaborator

Unity Health Toronto

OTHER

collaborator

Sir Mortimer B. Davis - Jewish General Hospital

OTHER

lead

Northern Therapeutics

INDUSTRY

NCT00469027 - Pulmonary Hypertension: Assessment of Cell Therapy | Biotech Hunter | Biotech Hunter